Xiaofan Hu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Obinutuzumab Compared to Cyclosporine with Steroids for the Treatment of Primary Membranous Nephropathy: A Propensity Score-Matched Analysis.
Journal: Kidney360
Published: January 16, 2026
A Clinicopathologic Study of Neural Epidermal Growth Factor-Like 1-Associated Membranous Nephropathy in a Chinese Cohort.
Journal: Kidney international reports
Published: January 05, 2026
Finerenone in Primary IgA Nephropathy: A Matched Case-Control Study.
Journal: Kidney diseases (Basel, Switzerland)
Published: November 07, 2024
Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 18, 2023
The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification.
Journal: Journal of clinical medicine
Published: November 09, 2023
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids.
Journal: Kidney diseases (Basel, Switzerland)
Published: October 17, 2023
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: August 14, 2023
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia.
Journal: Kidney diseases (Basel, Switzerland)
Published: April 03, 2020
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.
Journal: Nature communications
Published: August 28, 2019
Management of Membranous Nephropathy in Asia.
Journal: Kidney diseases (Basel, Switzerland)
Published: April 16, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026